Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1724 (LINC01724) is a human gene encoding a long intergenic non-protein coding RNA (lincRNA) with no evidence of protein-coding capability. LINC01724 is categorized as a long intergenic non-coding RNA, a subclass of long non-coding RNAs typically over 200 nucleotides in length, transcribed from genomic regions that do not overlap with protein-coding genes. While lincRNAs, in general, can regulate gene expression, act as molecular sponges for microRNAs, participate in chromatin modification, and impact diverse biological pathways, the direct biological functions, specific disease roles, and therapeutic targeting information for LINC01724 itself are currently limited and not well established in the scientific literature. LINC01724 is referenced in established gene compendia (GeneCards, BioGPS) with standard identifiers but without detailed function or disease association. It is not listed as a therapeutic target in any curated biomedical database, nor are any drugs reported to interact with it. There is no evidence to indicate that its name is incorrect or misspelled.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1724 (LINC01724).